Todd Franklin Watanabe - Reporting Person's title: President and Chief Executive Officer, Director at Arcutis Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Reporting Person's title: President and Chief Executive Officer, Director
Stock Symbol
ARQT on Nasdaq
All Insider Reports
All Insider Reports

Todd Franklin Watanabe - trading volume in the past year for Arcutis Biotherapeutics, Inc.

Holdings reported by Todd Franklin Watanabe for Arcutis Biotherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 804K $10.2M $12.70 Feb 3, 2025 Direct
Common Stock 125K $1.59M $12.70 Feb 3, 2025 By Trust
Common Stock 57.4K $728K $12.70 Feb 3, 2025 By LLC
Stock Option (right to buy) 0 Feb 13, 2024 Direct Common Stock

Transactions reported by Todd Franklin Watanabe for Arcutis Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.